| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| TST-003 | TST-003 | Phase 2 Clinical | Suzhou Transcenta Therapeutics Co Ltd | Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours | Details |
| Ginisortamab | UCB-6114 | Phase 2 Clinical | Ucb Biopharma Srl | Solid tumours | Details |